Skip to main content

Day: June 10, 2025

Historic Executive Order Fast-Tracks ZenaTech’s ZenaDrone Subsidiary Manufacturing and Go-to-Market Plans for Dual-Use Defense and Commercial Drones

VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces the fast tracking of its subsidiary ZenaDrone’s manufacturing and go-to-market plans for dual-use defense and commercial drones as a result of the recent June 6th White House executive order ‘Unleashing American Drone Dominance’. This directive accelerates FAA approvals, expands BVLOS (Beyond Visual Line of Sight) and eVTOL (electric Vertical Take-off and Landing) drone operations, and prioritizes US-made drones—unlocking significant commercial and military opportunities for American drone companies in what the AUVSI drone association...

Continue reading

Primech AI, Subsidiary of Primech Holdings Wins Robotics Category at Singapore Business Review Technology Excellence Awards 2025

SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) — Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced that it has been named Winner in the Robotics category at the prestigious Singapore Business Review (SBR) Technology Excellence Awards 2025. This recognition underscores Primech AI’s commitment to innovation and leadership in the robotics industry and its ongoing efforts to drive technological advancements that enhance productivity and transform industries. The SBR Technology Excellence Awards celebrate the achievements of Singapore’s top technology companies and innovators, highlighting organizations that have made significant contributions to the nation’s digital transformation journey. As detailed in the official SBR announcement, this year’s ceremony recognized...

Continue reading

Rush Street Interactive Launches Multi-State BetRivers Poker Network, Unifying Players Across Four States

Backed by two poker legends, Phil Hellmuth and Phil Galfond, BetRivers Poker Expands from Pennsylvania to the states of Michigan, Delaware, West Virginia CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced the launch of its proprietary online poker platform, BetRivers Poker, into Delaware, Michigan, and West Virginia. Following a successful debut in Pennsylvania last November, this multi-state expansion marks a major milestone: merging player pools across four states to create a larger, more competitive network. Players can now compete across state lines, resulting in bigger tournament prize pools, deeper cash-game fields, and more consistent action. The launch of a unified...

Continue reading

Genius Group Acquires Entrepreneur Resorts, Expands Genius City Model with 50% Increase in 2025 Revenue Guidance

SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has signed a binding asset purchase agreement with Entrepreneur Resorts Ltd (“ERL”), for the purchase and re-integration of ERL’s entrepreneur cafés and resorts into Genius Group, expanding its Genius City model and increasing by 50% its Company’s revenue guidance in 2025. ERL operates its entrepreneur café and resort model in Singapore, South Africa and Bali, Indonesia, combining co-working, retreats and accelerators in paradise locations. ERL had previously been a part of Genius Group and was spun off in September 2023, with the intent of providing all Genius Group investors shares in ERL in a special dividend, with the shares tradeable...

Continue reading

Lantheus to Present at the 2025 Truist Securities MedTech Conference

BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the 2025 Truist Securities MedTech Conference at 8:40 a.m. ET on Tuesday, June 17. To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation. About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better...

Continue reading

GSAC Engineering Secures Multi-Year Recurring Revenue Contract

GelStat’s Subsidiary Awarded Renewal for Security Monitoring Services and Expands Deployment of Proprietary iCAS Technology Across Three Secure Government-Operated Facilities in Florida MIAMI, June 10, 2025 (GLOBE NEWSWIRE) — GelStat Corporation (“GelStat” or the “Company”) (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, today announced the renewal of a service contract for its subsidiary, GSAC Engineering (“GSACe”), totaling approximately $550,000 over a four-year term. With expected additional work-orders the revenue could exceed $1 million over that period. Effective March 19, 2025, the agreement provides for structured recurring payments through January 31, 2029. The renewal includes...

Continue reading

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology

Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumatology, taking place June 11-14, 2025, in Barcelona, Spain. The Company’s presentation will feature data from the ongoing clinical study evaluating Allocetra™, Enlivex’s proprietary, off-the-shelf macrophage reprogramming cell therapy, in patients with knee osteoarthritis. Allocetra™ is designed to reprogram macrophages into a homeostatic state, thereby promoting immune balance and resolution of chronic inflammation. Allocetra™ has demonstrated favorable safety and promising efficacy signals in Phase...

Continue reading

NeoVolta Distributor Orders Top $3M in Single Quarter

Channel Momentum Highlights Growing Market Acceptance for NeoVolta Energy Storage Solutions SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable energy storage solutions for resilient residential and commercial power infrastructure, today announced that distributor purchase orders have exceeded $3 million in the current quarter—the highest quarterly total from the channel in company history. “These distributor orders represent a major milestone in our expansion strategy,” said Ardes Johnson, CEO of NeoVolta. “They show that demand for NeoVolta systems is scaling across the country through established installer networks—not just direct sales.” The surge in purchase orders came from three major solar and energy equipment distributors in the U.S. Their...

Continue reading

Iovance Biotherapeutics to Present at Upcoming Conference

SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conference:Goldman Sachs Global Healthcare ConferenceFireside Chat: June 11, 2025 at 1:20 p.m. ETMiami, FLThe live and archived webcasts will be available at https://ir.iovance.com/news-events/events-presentations. About Iovance Biotherapeutics, Inc.  Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing...

Continue reading

Itron Publishes 2024 Corporate Sustainability Report

Advances Emissions Goals, Completes Double Materiality Assessment and Highlights Positive Customer Impact LIBERTY LAKE, Wash., June 10, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, today released its 2024 Corporate Sustainability Report. The report details Itron’s environmental, social and governance (ESG) strategy and highlights how the company is empowering cities and utilities to boost efficiency, reduce emissions and build climate-resilient communities equipped to tackle a range of challenges including resource scarcity and infrastructure strain. “At Itron, sustainability is a responsibility we embrace every day,” said Tom Deitrich, president and CEO of Itron. “This year, Itron completed our first enterprise-wide double materiality assessment,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.